Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: Real-world advantage and challenge of post-autologous stem cell transplantation MRD negativity in high-risk patients with double-hit multiple myeloma

Fig. 1

The association of individual HRCA or the number of HRCA with clinical risk groups. (A) The distribution of individual HRCA or the number of HRCA by ISS sorted by the proportion of patients; (B) The contribution of individual HRCA or the number of HRCA to relapse sorted by the proportion of patients, with a breakdown of PFS over ≤ 18 months/ 18–36 months/>36 months, or no progression. HR, high risk; HRCA, high-risk cytogenetics; PD, progressive disease

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us